Zymeworks (ZYME) Misses Q4 EPS by 55c
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Join SI Premium – FREE
Zymeworks (NASDAQ: ZYME) reported Q4 EPS of ($0.55). Revenue for the quarter came in at $2.52 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Goldman Sachs updates view on protein markets ahead of earnings
- Prenetics IM8 revenue jumps 359% in Q2, raises FY2026 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
